Cancer Incidence and Mortality among Blacks, New York State Excl New York City, 2014-2018
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 5084.0 | 477.7 | 471.7-483.8 | 2638.4 | 568.2 | 558.0-578.6 | 2445.6 | 416.1 | 408.7-423.7 | 1499.8 | 151.1 | 147.6-154.6 | 751.0 | 184.9 | 178.7-191.3 | 748.8 | 129.8 | 125.6-134.1 |
| Oral cavity and pharynx | 88.8 | 8.1 | 7.4-8.9 | 61.4 | 12.5 | 11.1-14.1 | 27.4 | 4.7 | 3.9-5.5 | 19.8 | 1.9 | 1.5-2.3 | 14.0 | 3.0 | 2.3-3.9 | 5.8 | 1.0 | 0.7-1.4 |
| Esophagus | 41.8 | 4.2 | 3.6-4.8 | 27.2 | 6.6 | 5.5-7.9 | 14.6 | 2.5 | 2.0-3.2 | 29.0 | 2.9 | 2.4-3.5 | 21.0 | 5.1 | 4.2-6.3 | 8.0 | 1.4 | 1.0-1.9 |
| Stomach | 119.8 | 12.0 | 11.0-13.0 | 67.2 | 15.6 | 13.9-17.5 | 52.6 | 9.4 | 8.3-10.6 | 46.8 | 4.7 | 4.1-5.4 | 30.2 | 7.3 | 6.1-8.7 | 16.6 | 2.9 | 2.3-3.6 |
| Colorectal | 431.0 | 41.3 | 39.5-43.1 | 221.8 | 49.4 | 46.4-52.6 | 209.2 | 35.6 | 33.4-37.8 | 141.6 | 14.2 | 13.2-15.3 | 74.0 | 17.4 | 15.5-19.3 | 67.6 | 11.9 | 10.7-13.3 |
| Colon excluding rectum | 311.0 | 30.2 | 28.7-31.8 | 153.6 | 34.9 | 32.3-37.6 | 157.4 | 26.9 | 25.0-28.9 | 117.2 | 11.8 | 10.8-12.8 | 61.2 | 14.4 | 12.7-16.2 | 56.0 | 9.9 | 8.8-11.1 |
| Rectum & rectosigmoid | 120.0 | 11.1 | 10.2-12.1 | 68.2 | 14.5 | 12.9-16.2 | 51.8 | 8.7 | 7.6-9.8 | 24.4 | 2.5 | 2.0-3.0 | 12.8 | 3.0 | 2.3-3.9 | 11.6 | 2.0 | 1.5-2.6 |
| Liver / intrahepatic bile duct | 132.4 | 11.5 | 10.7-12.5 | 97.8 | 19.1 | 17.4-21.0 | 34.6 | 5.5 | 4.7-6.5 | 81.0 | 7.6 | 6.8-8.3 | 56.0 | 11.9 | 10.5-13.4 | 25.0 | 4.3 | 3.5-5.1 |
| Pancreas | 169.6 | 16.8 | 15.7-18.0 | 77.2 | 17.3 | 15.5-19.2 | 92.4 | 16.2 | 14.8-17.8 | 117.0 | 11.9 | 10.9-12.9 | 55.2 | 13.0 | 11.4-14.7 | 61.8 | 10.9 | 9.7-12.3 |
| Larynx | 39.4 | 3.7 | 3.2-4.2 | 31.6 | 6.9 | 5.8-8.2 | 7.8 | 1.2 | 0.9-1.7 | 12.6 | 1.3 | 1.0-1.6 | 10.6 | 2.6 | 1.9-3.4 | 2.0 | 0.3 | 0.2-0.6 |
| Lung and bronchus | 592.4 | 57.7 | 55.5-59.8 | 316.2 | 73.9 | 70.1-77.8 | 276.2 | 46.7 | 44.2-49.2 | 337.6 | 33.8 | 32.2-35.5 | 187.2 | 45.8 | 42.7-49.0 | 150.4 | 25.8 | 23.9-27.7 |
| Melanoma of the skin | 11.8 | 1.2 | 0.9-1.5 | 5.8 | 1.2 | 0.8-1.8 | 6.0 | 1.1 | 0.7-1.5 | 2.2 | 0.2 | 0.1-0.4 | 1.6 | 0.4 | 0.2-0.8 | 0.6 | 0.1 | 0.0-0.3 |
| Female breast | 756.6 | 128.5 | 124.4-132.7 | 131.8 | 22.5 | 20.8-24.3 | ||||||||||||
| Cervix uteri | 48.6 | 8.3 | 7.3-9.4 | 14.4 | 2.5 | 1.9-3.1 | ||||||||||||
| Corpus uterus and NOS | 178.2 | 29.5 | 27.6-31.5 | 50.6 | 8.7 | 7.6-9.8 | ||||||||||||
| Ovary | 51.4 | 8.7 | 7.6-9.8 | 29.8 | 5.1 | 4.3-6.1 | ||||||||||||
| Prostate | 989.2 | 203.1 | 197.2-209.2 | 97.2 | 28.6 | 26.0-31.3 | ||||||||||||
| Testis | 9.0 | 1.6 | 1.1-2.1 | 0.0 | 0.0 | 0.0-0.2 | ||||||||||||
| Urinary bladder (incl. in situ) | 127.6 | 13.0 | 12.0-14.1 | 84.6 | 20.6 | 18.6-22.8 | 43.0 | 7.6 | 6.6-8.7 | 24.2 | 2.6 | 2.2-3.2 | 15.0 | 4.3 | 3.3-5.4 | 9.2 | 1.6 | 1.2-2.2 |
| Kidney and renal pelvis | 213.4 | 19.6 | 18.4-20.9 | 134.8 | 27.5 | 25.4-29.8 | 78.6 | 13.4 | 12.1-14.8 | 27.6 | 2.7 | 2.3-3.3 | 19.6 | 4.5 | 3.6-5.5 | 8.0 | 1.5 | 1.0-2.0 |
| Brain and other central nervous system | 44.0 | 4.0 | 3.4-4.5 | 24.4 | 4.8 | 4.0-5.8 | 19.6 | 3.3 | 2.7-4.0 | 24.0 | 2.2 | 1.8-2.7 | 11.6 | 2.4 | 1.8-3.1 | 12.4 | 2.1 | 1.6-2.6 |
| Thyroid | 125.0 | 11.3 | 10.4-12.2 | 26.8 | 5.5 | 4.6-6.6 | 98.2 | 16.7 | 15.3-18.3 | 4.4 | 0.5 | 0.3-0.7 | 2.0 | 0.5 | 0.3-1.0 | 2.4 | 0.4 | 0.2-0.7 |
| Hodgkin lymphoma | 34.4 | 3.0 | 2.6-3.5 | 17.8 | 3.2 | 2.6-4.0 | 16.6 | 2.8 | 2.2-3.5 | 2.6 | 0.2 | 0.1-0.4 | 2.2 | 0.5 | 0.2-0.9 | 0.4 | 0.1 | 0.0-0.3 |
| Non-Hodgkin lymphomas | 167.4 | 15.8 | 14.7-16.9 | 89.2 | 19.2 | 17.3-21.2 | 78.2 | 13.3 | 12.0-14.8 | 39.8 | 4.0 | 3.4-4.6 | 24.0 | 5.7 | 4.7-6.9 | 15.8 | 2.8 | 2.2-3.5 |
| Myeloma | 155.6 | 15.0 | 13.9-16.1 | 83.0 | 18.8 | 16.9-20.8 | 72.6 | 12.3 | 11.0-13.6 | 47.6 | 5.0 | 4.4-5.7 | 22.4 | 5.9 | 4.8-7.2 | 25.2 | 4.5 | 3.8-5.4 |
| Leukemias | 118.4 | 11.3 | 10.4-12.2 | 67.4 | 15.0 | 13.3-16.7 | 51.0 | 8.7 | 7.7-9.9 | 48.8 | 5.0 | 4.4-5.7 | 25.0 | 6.3 | 5.2-7.5 | 23.8 | 4.2 | 3.4-5.0 |
Notes
- Incidence data are provisional, November 2020.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
